Bristol-Myers Squibb Company (BMY) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - General industry. The company is headquartered in Princeton, NJ, United States. The current CEO is Christopher S. Boerner.
BMY has IPO date of 1972-06-01, 34,100 full-time employees, listed on the NYSE, a market capitalization of $118.58B.
Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, licenses, manufactures, and markets innovative medicines across multiple therapeutic areas including oncology, cardiovascular disease, immunology, hematology, and neuroscience. The company's leading portfolio includes blockbuster drugs such as Revlimid for multiple myeloma, Eliquis for stroke prevention and blood clots, Opdivo for cancer treatment, and Orencia for rheumatoid arthritis, along with numerous other specialty pharmaceuticals addressing serious diseases. Bristol-Myers Squibb distributes its products through wholesalers, distributors, pharmacies, retailers, hospitals, and government agencies worldwide. Founded in 1887 and headquartered in New York, the company has established itself as a major player in the global pharmaceutical industry with a strong emphasis on advancing patient care through targeted biological therapies.
